West Pharmaceutical Services, Inc. WST
NYSE
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.25% | 3.24% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.25% | 3.24% | |||
| Cost of Revenue | -2.95% | -0.98% | |||
| Gross Profit | 5.53% | 11.07% | |||
| SG&A Expenses | -2.86% | 12.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -206.67% | 168.18% | |||
| Total Operating Expenses | -3.50% | 2.22% | |||
| Operating Income | 13.21% | 6.93% | |||
| Income Before Tax | 46.08% | 1.47% | |||
| Income Tax Expenses | 80.12% | -27.96% | |||
| Earnings from Continuing Operations | 38.96% | 10.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 38.96% | 10.95% | |||
| EBIT | 13.21% | 6.93% | |||
| EBITDA | 10.57% | 6.00% | |||
| EPS Basic | 39.75% | 12.83% | |||
| Normalized Basic EPS | 12.76% | 8.48% | |||
| EPS Diluted | 40.47% | 11.98% | |||
| Normalized Diluted EPS | 12.92% | 8.33% | |||
| Average Basic Shares Outstanding | -0.56% | -1.67% | |||
| Average Diluted Shares Outstanding | -0.70% | -1.52% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.29% | -0.10% | |||